1 乔杰.生殖医学临床诊疗常规[M].北京:人民军医出版社,2013:200-206.
2 孙玉菡,郝丽娟,林奕,等. 179例卵巢过度刺激综合征的临床特点[J]. 重庆医学,2014,43(31):4219-4224.
3 Rizk B,Aboulghar MA.Classification,pathophysiology and management of ovarian hyperstimulation syndrome[A].//Brinsden P.A textbook of in vitro fertilization and assisted reproduction[M].2nd ed.London: Parthenon Publishing Group,1999:131-135.
4 Golan A,Weissman A. Symposium:Update on prediction and management of OHSS. A modern classification of OHSS[J]. Reprod Biomed Online,2009,19(1):28-32.
5 裴雪婷,周平.自体腹水回输在卵巢过度刺激综合征治疗中的应用[J]. 国际生殖健康/计划生育杂志,2015,34(1):80-82.
6 全松,陈薪.卵巢过度刺激综合征的防治[J].中国实用妇科与产科杂志,2010,26(10):761-765.
7 Spitzer D,Wogatzky J,Murtinger M,et al. Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome[J]. Fertil Steril,2011,95 (8):2742-2744.
8 Westerlund E,Henriksson P,Wallén H,et al. Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis[J]. Thromb Res,2012,130(4):649-653.
9 杨艳丽,胡淑玲,任健康,等. 恶性肿瘤患者血浆D-二聚体检测的临床意义[J]. 临床输血与检验,2009,11(2):164-166.
10 Chipwete SE,Bugren S,Rafla N. Thrombosis post ovarian hyperstimulation[J].Fertil Steril,2009,91(5):1956.e13-4.
11 徐学静,夏永泉,张葵. 凝血纤溶指标在卵巢过度刺激综合征中的临床应用分析[J]. 国际检验医学杂志,2013,34(10):1219-1220.
12 迪丽努尔,卡米拉,阿尔孜古丽•木塔力甫. 分娩前孕妇血浆D二聚体与FDP联合检测的临床意义[J]. 血栓与止血学,2016,22(4):424-425. |